Liu Dawei, Long Jeffrey D, Zhang Ying, Raymond Lynn A, Marder Karen, Rosser Anne, McCusker Elizabeth A, Mills James A, Paulsen Jane S
Department of Psychiatry, Carver College of Medicine, The University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA.
Biogen, 300 Binney Street, Cambridge, MA, 02142, USA.
J Neurol. 2015 Dec;262(12):2691-8. doi: 10.1007/s00415-015-7900-7. Epub 2015 Sep 26.
Huntington disease (HD) is a neurodegenerative disorder characterized by motor dysfunction, cognitive deterioration, and psychiatric symptoms, with progressive motor impairments being a prominent feature. The primary objectives of this study are to delineate the disease course of motor function in HD, to provide estimates of the onset of motor impairments and motor diagnosis, and to examine the effects of genetic and demographic variables on the progression of motor impairments. Data from an international multisite, longitudinal observational study of 905 prodromal HD participants with cytosine-adenine-guanine (CAG) repeats of at least 36 and with at least two visits during the followup period from 2001 to 2012 was examined for changes in the diagnostic confidence level from the Unified Huntington's Disease Rating Scale. HD progression from unimpaired to impaired motor function, as well as the progression from motor impairment to diagnosis, was associated with the linear effect of age and CAG repeat length. Specifically, for every 1-year increase in age, the risk of transition in diagnostic confidence level increased by 11% (95% CI 7-15%) and for one repeat length increase in CAG, the risk of transition in diagnostic confidence level increased by 47% (95% CI 27-69%). Findings show that CAG repeat length and age increased the likelihood of the first onset of motor impairment as well as the age at diagnosis. Results suggest that more accurate estimates of HD onset age can be obtained by incorporating the current status of diagnostic confidence level into predictive models.
亨廷顿舞蹈症(HD)是一种神经退行性疾病,其特征为运动功能障碍、认知衰退和精神症状,进行性运动障碍是其突出特征。本研究的主要目的是描绘HD患者运动功能的疾病进程,估计运动障碍的发病时间和运动诊断情况,并研究基因和人口统计学变量对运动障碍进展的影响。我们对来自一项国际多中心纵向观察研究的数据进行了分析,该研究涉及905名前驱HD参与者,他们的胞嘧啶-腺嘌呤-鸟嘌呤(CAG)重复序列至少为36,且在2001年至2012年的随访期内至少有两次就诊记录,通过统一亨廷顿舞蹈症评定量表来检查诊断置信水平的变化。HD从不影响运动功能到出现运动功能障碍的进展,以及从运动障碍到确诊的进展,均与年龄和CAG重复序列长度的线性效应相关。具体而言,年龄每增加1岁,诊断置信水平转变的风险增加11%(95%置信区间7 - 15%),CAG重复序列长度每增加一个单位,诊断置信水平转变的风险增加47%(95%置信区间27 - 69%)。研究结果表明,CAG重复序列长度和年龄增加了首次出现运动障碍的可能性以及确诊年龄。结果表明,将诊断置信水平的当前状态纳入预测模型可以更准确地估计HD发病年龄。